Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM

NCT02301806 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

OTHER: dieting
DRUG: Sitagliptin
DRUG: Glimepiride

Sponsor

Dokkyo Medical University

Collaborators

[object Object]